• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Metformin and statins and their role in reducing hepatocellular carcinoma risk: Randomized trials are needed: Editorial on "Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy".

作者信息

Kwo Paul Y

机构信息

Division of Gastroenterology and Hepatology, Stanford University Medical School, Stanford, CA, USA.

出版信息

Clin Mol Hepatol. 2024 Oct;30(4):714-717. doi: 10.3350/cmh.2024.0425. Epub 2024 Jun 11.

DOI:10.3350/cmh.2024.0425
PMID:38858181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11540391/
Abstract
摘要

相似文献

1
Metformin and statins and their role in reducing hepatocellular carcinoma risk: Randomized trials are needed: Editorial on "Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy".二甲双胍和他汀类药物及其在降低肝细胞癌风险中的作用：需要进行随机试验：关于“二甲双胍和他汀类药物可降低抗病毒治疗失败的慢性丙型肝炎患者的肝细胞癌风险”的社论
Clin Mol Hepatol. 2024 Oct;30(4):714-717. doi: 10.3350/cmh.2024.0425. Epub 2024 Jun 11.
2
Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.二甲双胍和他汀类药物可降低抗病毒治疗失败的慢性丙型肝炎患者肝细胞癌的风险。
Clin Mol Hepatol. 2024 Jul;30(3):468-486. doi: 10.3350/cmh.2024.0038. Epub 2024 Apr 19.
3
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.在台湾，二甲双胍可降低糖尿病合并慢性丙型肝炎患者抗病毒治疗成功后的肝细胞癌发病率。
J Hepatol. 2023 Feb;78(2):281-292. doi: 10.1016/j.jhep.2022.09.019. Epub 2022 Oct 5.
4
Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin.通过纠正代谢异常预防肝细胞癌：他汀类药物和二甲双胍的作用
World J Hepatol. 2015 May 18;7(8):1105-11. doi: 10.4254/wjh.v7.i8.1105.
5
Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?二甲双胍与慢性丙型肝炎糖尿病患者肝细胞癌风险降低：事实还是虚构？
Viruses. 2023 Dec 17;15(12):2451. doi: 10.3390/v15122451.
6
Reply to correspondence on "Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy".对关于“二甲双胍和他汀类药物降低抗病毒治疗失败的慢性丙型肝炎患者肝细胞癌风险”的信件的回复
Clin Mol Hepatol. 2024 Oct;30(4):1050-1052. doi: 10.3350/cmh.2024.0546. Epub 2024 Jul 12.
7
Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysis.围手术期使用他汀类药物、二甲双胍和阿司匹林与肝细胞癌患者根治性肝切除术后复发的相关性：倾向评分匹配分析。
Cancer Med. 2023 Oct;12(19):19548-19559. doi: 10.1002/cam4.6569. Epub 2023 Sep 22.
8
Metformin as adjuvant treatment in hepatitis C virus infections and associated complications.二甲双胍作为辅助治疗丙型肝炎病毒感染及相关并发症的应用。
Am J Med Sci. 2024 Aug;368(2):90-98. doi: 10.1016/j.amjms.2024.04.019. Epub 2024 May 1.
9
Statins in Hepatitis B or C Patients Is Associated With Reduced Hepatocellular Carcinoma Risk: A Systematic Review and Meta-Analysis.他汀类药物在乙型或丙型肝炎患者中与降低肝细胞癌风险相关：系统评价和荟萃分析。
Turk J Gastroenterol. 2022 Feb;33(2):136-144. doi: 10.5152/tjg.2020.19656.
10
Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.荟萃分析：他汀类药物、阿司匹林和二甲双胍预防肝细胞癌。
Aliment Pharmacol Ther. 2023 Mar;57(6):600-609. doi: 10.1111/apt.17371. Epub 2023 Jan 10.

引用本文的文献

1
Metformin in Antiviral Therapy: Evidence and Perspectives.二甲双胍在抗病毒治疗中的应用：证据与展望
Viruses. 2024 Dec 18;16(12):1938. doi: 10.3390/v16121938.
2
Reply to correspondence on "Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy".对关于“二甲双胍和他汀类药物降低抗病毒治疗失败的慢性丙型肝炎患者肝细胞癌风险”的信件的回复
Clin Mol Hepatol. 2024 Oct;30(4):1050-1052. doi: 10.3350/cmh.2024.0546. Epub 2024 Jul 12.

本文引用的文献

1
Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes.GLP-1 受体激动剂与 2 型糖尿病患者肝癌发病率和肝功能失代偿的相关性。
Gastroenterology. 2024 Sep;167(4):689-703. doi: 10.1053/j.gastro.2024.04.029. Epub 2024 Apr 29.
2
Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.二甲双胍和他汀类药物可降低抗病毒治疗失败的慢性丙型肝炎患者肝细胞癌的风险。
Clin Mol Hepatol. 2024 Jul;30(3):468-486. doi: 10.3350/cmh.2024.0038. Epub 2024 Apr 19.
3
Management of type 2 diabetes in patients with compensated liver cirrhosis: Short of evidence, plenty of potential.代偿期肝硬化患者的2型糖尿病管理：证据不足，潜力巨大。
Diabetes Metab Syndr. 2024 Jan;18(1):102935. doi: 10.1016/j.dsx.2023.102935. Epub 2023 Dec 28.
4
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.在台湾，二甲双胍可降低糖尿病合并慢性丙型肝炎患者抗病毒治疗成功后的肝细胞癌发病率。
J Hepatol. 2023 Feb;78(2):281-292. doi: 10.1016/j.jhep.2022.09.019. Epub 2022 Oct 5.
5
Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?他汀类药物和阿司匹林用于肝癌的化学预防：现在使用还是等待进一步研究？
Clin Mol Hepatol. 2022 Jul;28(3):380-395. doi: 10.3350/cmh.2021.0366. Epub 2022 Jan 13.
6
Efficacy and Safety of Statin for Hepatocellular Carcinoma Prevention Among Chronic Liver Disease Patients: A Systematic Review and Meta-analysis.他汀类药物预防慢性肝病患者肝细胞癌的疗效和安全性：系统评价和荟萃分析。
J Clin Gastroenterol. 2021 Aug 1;55(7):615-623. doi: 10.1097/MCG.0000000000001478.
7
Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.脂溶性他汀类药物与慢性病毒性肝炎患者肝细胞癌和死亡风险：来自瑞典全国人群的结果。
Ann Intern Med. 2019 Sep 3;171(5):318-327. doi: 10.7326/M18-2753. Epub 2019 Aug 20.
8
Global Elimination of Chronic Hepatitis.全球消除慢性肝炎
N Engl J Med. 2019 May 23;380(21):2041-2050. doi: 10.1056/NEJMra1810477.
9
Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy.丙型肝炎：从炎症发病机制到抗炎/肝保护治疗。
World J Gastroenterol. 2018 Dec 21;24(47):5297-5311. doi: 10.3748/wjg.v24.i47.5297.
10
What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats.消除乙型肝炎病毒和丙型肝炎病毒作为全球健康威胁需要什么。
Gastroenterology. 2019 Jan;156(2):297-310. doi: 10.1053/j.gastro.2018.10.048. Epub 2018 Nov 2.